Alternatives to Enveda

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Leveraging quantum mechanics for accelerated molecular simulations in drug discovery.

Developing novel therapeutics to restore gut lymphatic function.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

AI-powered platform for antibody discovery and development to create new medicines.

Leveraging the adaptive immune system to diagnose and treat disease.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

AI-powered platform for personalized cell therapy development and manufacturing.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

One Biosciences is a French biotech startup leveraging single-cell multi-omics and AI to discover novel drug targets for complex diseases.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Leveraging AI and a massive patient tissue dataset to accelerate drug discovery and advance precision medicine.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

A global oncology company developing and commercializing innovative cancer treatments.

Developing engineered biologics to harness the immune system for disease treatment.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Mapping cell-cell communication at scale in human tissue.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage precision medicine company using protein motion insights for drug discovery.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Discovers autoimmune drugs by mining proteins from parasites, viruses, and ticks with AI.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Advance every cancer decision.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Mining biological information for transformative peptide medicines.

BioGene Therapeutics is a life sciences company developing novel gene therapy solutions for metabolic disorders like diabetes and obesity.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Global marketplace connecting researchers with human biospecimens for life science research.

AI-powered spatial biology platform for precision medicine and drug development.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

Biotech company focused on designing and developing novel biological solutions.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

Biotechnology company

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

Biostax provides a cloud-based platform for life sciences research, enabling data integration and analysis.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

AI-powered platform accelerating biological research and drug discovery.